American College of Rheumatology Arthritis and Rheumatism. May ;64 5 Yeomans ND. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. N Engl J Med ; Silverstein, et al.
Gastrointestinal toxicity with celecoxib vs. JAMA ; Risk of cardiovascular events associated with selective COX-2 inhibitors. Juni, et al. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs. BMJ ; Solomon DH, et al. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.
Circulation ; 17 Greenwood Village, Colo: Thomson Healthcare. Updated periodically. Accessed May 27, The material provided to you are guidelines used by this plan to authorize, modify or determine coverage for persons with similar illnesses or conditions.
Specific care and treatment may vary depending on individual need and the benefits covered under your contract. Similar changes were observed in the secondary analysis. No other changes in medical service encounters were noted after the PA policy was activated. Conclusions: This observational study found that celecoxib use was substantially reduced after the implementation of a PA policy.
No important changes in use of other drug classes were detected. The overall increase in emergency-department visits--although not observed among previous NSAID users--should be explored on the individual level.
Abstract Background: Prior authorization PA is a poorly studied but commonly employed policy used by health care payers to manage the rising costs of pharmacy benefits. Publication types Research Support, Non-U.
0コメント